Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer

@article{Song2017IncidenceOT,
  title={Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer},
  author={Su Song and Ji Hye Min and Sung Yun Suh and Sun Hoi Jung and Hyeon Joo Hahn and Seock-Ah Im and Ju-Yeun Lee},
  journal={Supportive Care in Cancer},
  year={2017},
  volume={25},
  pages={2241-2248}
}
Taxane-induced peripheral neuropathy (TIPN) can affect quality of life and treatment outcomes in breast cancer patients. Despite the high incidence, treatment of PN has not been established. This study aimed to evaluate the incidence, risk factors, and prescribing pattern of TIPN receiving pharmacologic treatment in real-world practice. We conducted a retrospective chart review of 1629 breast cancer patients who received taxanes at the Seoul National University Hospital from July 2012 to June… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 28 references

a singlecenter experience

  • B Bhatnagar, S Gilmore, +6 authors settings Bao T Chemotherapy dose reduction due to chemother adjuvant
  • Springerplus 3:366 2248 Support Care Cancer
  • 2017
1 Excerpt

Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199

  • BP Schneider, L Li, +20 authors GW JrSledge
  • Clin Cancer Res
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…